Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin-based regimen for pulmonary tuberculosis
NCT00144417Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Feb 2006
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of moxifloxacin in Tuberculosis (TB), sponsored by Centers for Disease Control and Prevention. Started Feb 2006; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00144417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144417.